Estrogen Receptor Dependent Inhibitors of NF-κB Transcriptional Activation-1 Synthesis and Biological Evaluation of Substituted 2-Cyanopropanoic Acid Derivatives:  Pathway Selective Inhibitors of NF-κB, a Potential Treatment for Rheumatoid Arthritis

Thomas J. Caggiano, Antony Brazzale, Douglas M. Ho, Christina M. Kraml, Eugene J. Trybulski, Christopher C. Chadwick, Sue Chippari, Lisa Borges-Marcucci, A Eckert, James C. Keith,

Journal of Medicinal Chemistry · 2007 · 13 citations · 5 references

DOIFull text

Open access

Concepts

Abstract

Pathway selective ligands of the estrogen receptor inhibit transcriptional activation of proinflammatory genes mediated by NF-kappaB. Substituted 2-cyanopropanoic acid derivatives were developed leading to the discovery of WAY-204688, an orally active, pathway selective, estrogen receptor dependent anti-inflammatory agent. This propanamide was shown to be orally active in preclinical models of inflammatory diseases, such as rheumatoid arthritis, without the proliferative effect associated with traditional estrogens.

References

5